Amlodipine, initially approved by the FDA in 1987, is a popular antihypertensive drug belonging to the group of drugs called dihydropyridine calcium channel blockers. Due to their selectivity for the peripheral blood vessels, dihydropyridine calcium channel blockers are associated with a lower incidence of myocardial depression and cardiac conduction abnorma...
Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions :
• Hypertension
• Coronary artery disease
• Chronic stable angina
• Vasospastic angina (Prinzmetal’s or Variant angina)
...
Novartis Investigative Sites, USA, New Jersey, United States
30 sites in Germany
Novartis Investigative Site, , Germany, Schwerin, Germany
Novartis Investigative Site, Hannover, Germany
25 centers in Germany, Ludwigshafen, Germany
Pfizer Investigational Site, Fukuoka, Japan
Sites in USA, East Hanover, New Jersey, United States
Novartis Pharmaceuticals, Tokyo, Japan
Novartis Investigative Site, Santa Monica, California, United States
Pfizer Investigational Site, Fukuoka, Japan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.